Our system continuously monitors global scientific databases, including PubMed, to identify new human studies on cannabinoids. Each entry is tagged by indication, cannabinoid type, and study design, allowing you to filter by what matters most.

We exclude pre-clinical and animal research, focusing solely on data with direct clinical relevance — randomised controlled trials, observational studies, and systematic reviews.

All study summaries are auto-generated from publicly available abstracts and are intended for informational purposes only.

Business of Cannabis summarises publicly available research to support clinical, regulatory and investment decision-making. These summaries are not a substitute for professional medical advice or prescribing guidance.